Annual Total Expenses
$202.37 M
+$5.06 M+2.56%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual total expenses is $202.37 million, with the most recent change of +$5.06 million (+2.56%) on December 31, 2023.
- During the last 3 years, PBYI annual total expenses has fallen by -$53.14 million (-20.80%).
- PBYI annual total expenses is now -41.45% below its all-time high of $345.65 million, reached on December 31, 2018.
Performance
PBYI Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$58.46 M
+$9.20 M+18.68%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly total expenses is $58.46 million, with the most recent change of +$9.20 million (+18.68%) on September 30, 2024.
- Over the past year, PBYI quarterly total expenses has increased by +$11.56 million (+24.64%).
- PBYI quarterly total expenses is now -36.60% below its all-time high of $92.21 million, reached on June 30, 2018.
Performance
PBYI Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PBYI Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.6% | +24.6% |
| 3 y3 years | -20.8% | +23.2% |
| 5 y5 years | -41.5% | +23.2% |
PBYI Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.6% | +2.6% | at high | +26.9% |
| 5 y | 5-year | -35.0% | +2.6% | -25.1% | +26.9% |
| alltime | all time | -41.5% | >+9999.0% | -36.6% | >+9999.0% |
Puma Biotechnology Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $58.46 M(+18.7%) |
| Jun 2024 | - | $49.26 M(+6.9%) |
| Mar 2024 | - | $46.06 M(-19.7%) |
| Dec 2023 | $202.37 M(+2.6%) | $57.38 M(+22.3%) |
| Sep 2023 | - | $46.91 M(-5.6%) |
| Jun 2023 | - | $49.68 M(+2.6%) |
| Mar 2023 | - | $48.41 M(-13.0%) |
| Dec 2022 | $197.31 M(-21.7%) | $55.66 M(+16.7%) |
| Sep 2022 | - | $47.71 M(+0.5%) |
| Jun 2022 | - | $47.46 M(+2.1%) |
| Mar 2022 | - | $46.48 M(-4.2%) |
| Dec 2021 | $251.87 M(-1.4%) | $48.52 M(-12.1%) |
| Sep 2021 | - | $55.20 M(-21.2%) |
| Jun 2021 | - | $70.02 M(-10.3%) |
| Mar 2021 | - | $78.02 M(+22.5%) |
| Dec 2020 | $255.51 M(-17.9%) | $63.71 M(+1.3%) |
| Sep 2020 | - | $62.88 M(-0.9%) |
| Jun 2020 | - | $63.45 M(-3.1%) |
| Mar 2020 | - | $65.47 M(-8.5%) |
| Dec 2019 | $311.31 M(-9.9%) | $71.59 M(+1.1%) |
| Sep 2019 | - | $70.80 M(-11.2%) |
| Jun 2019 | - | $79.70 M(-10.7%) |
| Mar 2019 | - | $89.22 M(-0.4%) |
| Dec 2018 | $345.65 M(+8.0%) | $89.62 M(+21.3%) |
| Sep 2018 | - | $73.91 M(-19.8%) |
| Jun 2018 | - | $92.21 M(+2.6%) |
| Mar 2018 | - | $89.91 M(+5.6%) |
| Dec 2017 | $320.07 M(+15.7%) | $85.17 M(+2.0%) |
| Sep 2017 | - | $83.52 M(+6.8%) |
| Jun 2017 | - | $78.18 M(+6.8%) |
| Mar 2017 | - | $73.20 M(+0.5%) |
| Dec 2016 | $276.60 M | $72.87 M(+10.4%) |
| Sep 2016 | - | $66.00 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $66.48 M(-6.7%) |
| Mar 2016 | - | $71.25 M(+14.8%) |
| Dec 2015 | $240.28 M(+68.9%) | $62.03 M(+2.1%) |
| Sep 2015 | - | $60.73 M(-6.4%) |
| Jun 2015 | - | $64.91 M(+23.4%) |
| Mar 2015 | - | $52.60 M(+10.5%) |
| Dec 2014 | $142.28 M(+159.5%) | $47.59 M(+32.4%) |
| Sep 2014 | - | $35.96 M(-7.6%) |
| Jun 2014 | - | $38.91 M(+96.3%) |
| Mar 2014 | - | $19.82 M(+24.0%) |
| Dec 2013 | $54.83 M(-26.3%) | $15.99 M(+11.6%) |
| Sep 2013 | - | $14.33 M(+12.8%) |
| Jun 2013 | - | $12.71 M(+7.6%) |
| Mar 2013 | - | $11.81 M(-46.2%) |
| Dec 2012 | $74.45 M(+633.0%) | $21.95 M(-15.2%) |
| Sep 2012 | - | $25.87 M(+75.1%) |
| Jun 2012 | - | $14.78 M(+24.7%) |
| Mar 2012 | - | $11.85 M(+21.1%) |
| Dec 2011 | $10.16 M(>+9900.0%) | $9.78 M(+2830.5%) |
| Sep 2011 | - | $333.90 K(+873.5%) |
| Jun 2011 | - | $34.30 K(+779.5%) |
| Mar 2011 | - | $3900.00(-218.2%) |
| Dec 2010 | $7000.00(-58.3%) | -$3300.00(-203.1%) |
| Sep 2010 | - | $3200.00(+33.3%) |
| Jun 2010 | - | $2400.00(-48.9%) |
| Mar 2010 | - | $4700.00(+42.4%) |
| Dec 2009 | $16.80 K(+19.1%) | $3300.00(0.0%) |
| Sep 2009 | - | $3300.00(-21.4%) |
| Jun 2009 | - | $4200.00(-30.0%) |
| Mar 2009 | - | $6000.00(+172.7%) |
| Dec 2008 | $14.10 K | $2200.00(-45.0%) |
| Sep 2008 | - | $4000.00(+17.6%) |
| Jun 2008 | - | $3400.00(-24.4%) |
| Mar 2008 | - | $4500.00 |
FAQ
- What is Puma Biotechnology annual total expenses?
- What is the all time high annual total expenses for Puma Biotechnology?
- What is Puma Biotechnology annual total expenses year-on-year change?
- What is Puma Biotechnology quarterly total expenses?
- What is the all time high quarterly total expenses for Puma Biotechnology?
- What is Puma Biotechnology quarterly total expenses year-on-year change?
What is Puma Biotechnology annual total expenses?
The current annual total expenses of PBYI is $202.37 M
What is the all time high annual total expenses for Puma Biotechnology?
Puma Biotechnology all-time high annual total expenses is $345.65 M
What is Puma Biotechnology annual total expenses year-on-year change?
Over the past year, PBYI annual total expenses has changed by +$5.06 M (+2.56%)
What is Puma Biotechnology quarterly total expenses?
The current quarterly total expenses of PBYI is $58.46 M
What is the all time high quarterly total expenses for Puma Biotechnology?
Puma Biotechnology all-time high quarterly total expenses is $92.21 M
What is Puma Biotechnology quarterly total expenses year-on-year change?
Over the past year, PBYI quarterly total expenses has changed by +$11.56 M (+24.64%)